Aspirin allergy labeling after desensitization: education, communication, and patient safety.
Publication
, Journal Article
Mullur, J; Laidlaw, TM
Published in: J Allergy Clin Immunol Pract
2020
Duke Scholars
Published In
J Allergy Clin Immunol Pract
DOI
EISSN
2213-2201
Publication Date
2020
Volume
8
Issue
10
Start / End Page
3629 / 3630.e1
Location
United States
Related Subject Headings
- Patient Safety
- Humans
- Drug Hypersensitivity
- Desensitization, Immunologic
- Communication
- Aspirin
- Anti-Inflammatory Agents, Non-Steroidal
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Mullur, J., & Laidlaw, T. M. (2020). Aspirin allergy labeling after desensitization: education, communication, and patient safety. J Allergy Clin Immunol Pract, 8(10), 3629-3630.e1. https://doi.org/10.1016/j.jaip.2020.06.018
Mullur, Jyotsna, and Tanya M. Laidlaw. “Aspirin allergy labeling after desensitization: education, communication, and patient safety.” J Allergy Clin Immunol Pract 8, no. 10 (2020): 3629-3630.e1. https://doi.org/10.1016/j.jaip.2020.06.018.
Mullur J, Laidlaw TM. Aspirin allergy labeling after desensitization: education, communication, and patient safety. J Allergy Clin Immunol Pract. 2020;8(10):3629-3630.e1.
Mullur, Jyotsna, and Tanya M. Laidlaw. “Aspirin allergy labeling after desensitization: education, communication, and patient safety.” J Allergy Clin Immunol Pract, vol. 8, no. 10, 2020, pp. 3629-3630.e1. Pubmed, doi:10.1016/j.jaip.2020.06.018.
Mullur J, Laidlaw TM. Aspirin allergy labeling after desensitization: education, communication, and patient safety. J Allergy Clin Immunol Pract. 2020;8(10):3629-3630.e1.
Published In
J Allergy Clin Immunol Pract
DOI
EISSN
2213-2201
Publication Date
2020
Volume
8
Issue
10
Start / End Page
3629 / 3630.e1
Location
United States
Related Subject Headings
- Patient Safety
- Humans
- Drug Hypersensitivity
- Desensitization, Immunologic
- Communication
- Aspirin
- Anti-Inflammatory Agents, Non-Steroidal
- 3204 Immunology